Merck & Company (6MK) Ownership - Who Owns Merck & Company?
Merck & Company (6MK) Ownership Overview
- 0.05% Insiders
- 21.78% Mutual Funds
- 3.42% Other Institutional Investors
- 25.68% ETFs
- 49.07% Public Companies and Individual Investors
The ownership structure of Merck & Company (DE:6MK) stock is a mix of institutional, retail, and individual investors. Approximately 50.89% of the company’s stock is owned by Institutional Investors, 0.05% is owned by Insiders, and 49.07% is owned by Public Companies and Individual Investors.
The ownership structure of Merck & Company (DE:6MK) stock is a mix of institutional, retail, and individual investors. Approximately 50.89% of the company’s stock is owned by Institutional Investors, 0.05% is owned by Insiders, and 49.07% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| Aug 12, 2026 | Chirfi Guindo | $1,350,000 | |
| Aug 12, 2026 | Jennifer Zachary | $10,718,037 | |
| Aug 11, 2026 | Richard Deluca | $5,942,179 | |
| Aug 09, 2026 | Richard Deluca | $788,764 |
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2025 | Howard Hughes Medical Institute | €56,208 | |
| Dec 31, 2025 | Esl Trust Services, Llc | €126,312 | |
| Dec 31, 2025 | Arq Wealth Advisors, Llc | €244,624 | |
| Dec 31, 2025 | Private Capital Management, Llc | €244,729 |
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard | 222,649,975 | Institution | 9.02% | 33,511,938,337 |
| Vanguard Index Funds | 168,800,432 | Institution | 6.84% | 25,406,828,222 |
| Ishares | 131,297,090 | Institution | 5.32% | 19,762,050,204 |
| Spdr | 104,689,488 | Institution | 4.24% | 15,757,233,597 |
| Fidelity Concord Street Trust | 43,192,109 | Institution | 1.75% | 6,501,017,094 |
| Ken Fisher | 38,516,263 | Institution | 1.56% | 5,797,236,809 |
| Vanguard Specialized Funds | 38,015,342 | Institution | 1.54% | 5,721,841,186 |
| Schwab | 37,976,234 | Institution | 1.54% | 5,715,954,884 |
| Amundi | 37,455,498 | Institution | 1.52% | 5,637,576,826 |
| Invesco | 20,626,813 | Institution | 0.84% | 3,104,624,132 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Index Funds | 168,800,432 | Institution | 6.84% | 25,406,828,222 |
| Fidelity Concord Street Trust | 43,192,109 | Institution | 1.75% | 6,501,017,094 |
| Vanguard Specialized Funds | 38,015,342 | Institution | 1.54% | 5,721,841,186 |
| Vanguard Institutional Index Funds | 14,589,877 | Institution | 0.59% | 2,195,980,747 |
| Vanguard World Fund | 13,496,143 | Institution | 0.55% | 2,031,358,468 |
| Jpmorgan Trust Ii | 12,739,548 | Institution | 0.52% | 1,917,480,328 |
| Vanguard Fenway Funds | 12,367,541 | Institution | 0.50% | 1,861,488,066 |
| Vanguard Whitehall Funds | 10,373,186 | Institution | 0.42% | 1,561,309,718 |
| Tiaa-cref Funds | 10,246,664 | Institution | 0.42% | 1,542,266,385 |
| Fidelity Rutland Square Trust Ii | 9,661,795 | Institution | 0.39% | 1,454,235,413 |
FAQ
Who Owns Merck & Company (DE:6MK)?
According to the latest TipRanks data, approximately 50.89% of the company's stock is held by institutional investors, 0.05% is held by insiders, and 49.07% is held by public companies and individual investors.
What percentage of Merck & Company (DE:6MK) stock is held by institutional investors?
According to the latest TipRanks data, approximately 50.89% of Merck & Company (DE:6MK) stock is held by institutional investors: 21.78% by mutual funds, 25.68% by ETFs and 3.42% by other institutional investors.
What percentage of Merck & Company (DE:6MK) stock is held by retail investors?
According to the latest TipRanks data, approximately 49.07% of Merck & Company (DE:6MK) stock is held by public companies and individual investors.
Who owns the most shares of Merck & Company (DE:6MK)?
Vanguard owns the most shares of Merck & Company (DE:6MK).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.